Upgrade to SI Premium - Free Trial

Merck (MRK) Stock Gains on Beat-and-Raise, Sees Up To $7 Billion in Sales of COVID-19 Drug, Analysts Bullish

October 28, 2021 9:21 AM
Shares of Merck (NYSE: MRK) are up 1.5% in pre-open Thursday after the biotech company delivered better-than-expected Q3 results.Merck said ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Earnings Guidance

Next Articles